Advertisement
Device Companies
Subscribe to Device Companies
View Sample

FREE Email Newsletter

Smith & Nephew to Buy ArthroCare in $1.5B Deal

February 3, 2014 10:24 am | by The Associated Press | News | Comments

British medical technology company Smith & Nephew plans to buy U.S. medical device maker ArthroCare in a $1.5 billion deal that it says will strengthen its sports medicine business. Smith & Nephew said Monday it will pay $48.25 in...

Abbott shutters Puerto Rico facility

January 31, 2014 2:04 pm | by Mass Device | News | Comments

Abbott is reportedly shutting down a Puerto Rico manufacturing plant, with an unspecified number of employees slated for termination. The plant in question resides in a city called Barceloneta, and the facility houses pharmaceutical...  

‘Smart’ Infusion Pumps See Fast Growth

January 31, 2014 11:58 am | by Kalorama Information | News | Comments

New "smart" infusion pump devices that can assist healthcare professionals in patient care through computer algorithms, warning features and connectivity are leading growth in the world market for infusion devices, according to Kalorama...

Advertisement

Covidien Receives Japanese Regulatory Approval for Reinforced Stapling Reload Technology

January 27, 2014 5:11 pm | by The Associated Press | News | Comments

Covidien plc has announced that its Japanese subsidiary, Covidien Japan Inc., has received Shonin approval from the Japanese Ministry of Health, Labor and Welfare for its Endo GIA Reinforced Reload with Tri-Staple technology. This approval...

St. Jude Medical Announces Implant of World’s First Leadless Pacemaker in the UK

January 27, 2014 1:12 am | by The Associated Press | News | Comments

St. Jude Medical, Inc., a global medical device company, today announced the first post-approval implant of the Nanostim leadless pacemaker in the U.K. The world’s first retrievable leadless pacemaker was implanted at St. Bartholomew’s Hospital...

Gagnon Cardiovascular Institute At Morristown Medical Center Implants Newly Approved Device To Replace Failing Aortic Heart Valves

January 24, 2014 4:38 pm | by PR Newswire | News | Comments

The Gagnon Cardiovascular Institute at Morristown Medical Center today became the first hospital in the tri-state area to adopt a new minimally invasive medical device to treat patients with severe aortic stenosis who are too ill or frail...

Covidien Receives FDA Clearance for LigaSure Maryland Jaw

January 23, 2014 11:17 am | by Business Wire | News | Comments

Expanding its industry-leading vessel and tissue sealing portfolio, Covidien received U.S. Food and Drug Administration (FDA) 510(k) clearance for the LigaSure Maryland jaw open/laparoscopic sealer/divider. In addition, Covidien completed...

Medtronic Pacing Systems First to Be Approved for Full Body MRI Scans Without Positioning Restrictions

January 23, 2014 11:10 am | by Medtronic | News | Comments

Medtronic, Inc. has announced that the Medtronic SureScan pacing systems—the first and only pacing systems in the United States that have been approved by the U.S. Food and Drug Administration (FDA) for use with magnetic resonance imaging...

Advertisement

GE Will Buy Software Maker API Healthcare

January 22, 2014 11:34 am | by The Associated Press | News | Comments

GE Healthcare said Tuesday that it will buy API Healthcare, which makes software for hospitals and health care staffing agencies. The General Electric Co. unit did not disclose terms of the deal, but said it expects to complete the acquisition...

Covidien to Exit OneShot Renal Denervation Program

January 21, 2014 10:46 am | by Business Wire | News | Comments

Covidien plc has announced it will exit its OneShot Renal Denervation program. This voluntary action is primarily in response to slower than expected development of the renal denervation market. The OneShot system is an over-the-wire...   

Philips Healthcare teams with P-Cure on proton therapy

January 20, 2014 4:29 pm | by Mass Device | News | Comments

Philips aligned itself with Israel-based medical device company P-Cure, in order to advance the smaller firm's proton therapy technology. P-Cure develops low-cost proton therapy systems, which are smaller, cheaper radiation therapy system...

Medtronic CoreValve System Obtains Early FDA Approval on Exceptional Clinical Performance

January 17, 2014 11:17 am | by The Associated Press | News | Comments

Medtronic today announced the U.S. Food and Drug Administration approval of the self-expanding transcatheter CoreValve System for severe aortic stenosis patients who are too ill or frail to have their aortic valves replaced through traditional...

Renal denervation is 'highly unlikely,' says Medtronic study insider

January 16, 2014 6:13 pm | by Mass Device | News | Comments

The future of renal denervation in treatment of hypertension is shaky at best, according to one of the principal investigators involved with Medtronic's disappointing clinical trial. Despite continued optimism from some of medtech's biggest players...

Advertisement

Covidien Completes Sale of Confluent Surgical to Integra LifeSciences

January 16, 2014 11:26 am | by Business Wire | News | Comments

Covidien plc today announced that it has completed the sale of its Confluent Surgical product line to Integra LifeSciences Corporation for approximately $235 million in cash. In addition, Covidien may receive up to an additional $30 million...

Jury says Medtronic owes Edwards about $390M

January 16, 2014 11:24 am | by The Associated Press | News | Comments

A federal jury ruled Wednesday that medical device maker Medtronic infringed on a patent held by Edwards Lifesciences and ordered Medtronic to pay its competitor about $390 million in damages. Edwards said it will seek a permanent injunction...

Johnson & Johnson’s Ortho-Clinical Diagnostics Acquired for $4.15 Billion

January 16, 2014 11:23 am | by Business Wire | News | Comments

Global alternative asset manager The Carlyle Group has agreed to acquire Johnson & Johnson’s Ortho-Clinical Diagnostics (OCD) business, a global provider of solutions for screening, diagnosing, monitoring and confirming diseases, for...

FDA dings Philips on InnerCool RTx component recall

January 15, 2014 5:09 pm | by Mass Device | News | Comments

The FDA dinged Philips for tardiness in its notification of the recall of a component for its InnerCool RTx body temperature control device in a warning letter sent last month. Philips issued a recall in January 2012 of the main control board for the...

Integra LifeSciences Completes Acquisition of DuraSeal Product Lines From Covidien

January 15, 2014 2:45 pm | by GlobeNewswire | News | Comments

Integra LifeSciences Holdings Corporation today announced that it has completed the acquisition of DuraSeal product lines from Covidien. Now, together with our DuraGen family of grafts, Integra offers surgeons the largest portfolio of dural repair...

Stryker affirms 2013 guidance, offers limited glimpse of Mako plans

January 15, 2014 1:17 pm | by Mass Device | News | Comments

Stryker CEO Kevin Lobo told an audience at the J.P. Morgan Healthcare conference this morning that its prior guidance for 2013 still holds true and provided a peek at the blockbuster Mako Surgical acquisition the medtech company closed 3 weeks...

Medtronic to Appeal Federal District Court Verdict

January 15, 2014 11:58 am | by Medtronic | News | Comments

A jury in the Federal District Court of Delaware today decided in favor of Edwards Lifesciences, ruling that the Medtronic CoreValve® System infringed on Edward's Cribier patent (US Pat. No. 8,002,825). Medtronic intends to appeal. "While...

Smith & Nephew Co-Sponsors Competition for Entrepreneurial Medical Device Companies

January 14, 2014 11:17 am | by PR Newswire | News | Comments

Smith & Nephew, the global medical technology business, is proud to announce it will co-sponsor the 2014 Massachusetts Medical Device Development (M2D2) Center's New Venture Competition. Designed to showcase innovative ideas coming out...

Medtronic CEO: Value-based healthcare is the only way to save medtech

January 13, 2014 6:35 pm | by Mass Device | News | Comments

There's been a lot of hand-wringing in medtech as healthcare systems around the world have moved from fee-for-service to value-based healthcare models that reward for outcomes, rather than for specific procedures. But for Medtronic CEO Omar...

St. Jude CEO: Medtronic's renal denervation miss doesn't dampen our spirits

January 13, 2014 5:55 pm | by Mass Device | News | Comments

St. Jude Medical CEO Daniel Starks remains steadfast in his pursuit of renal denervation in treatment of hypertension, despite the high-profile clinical trial flop suffered just last week by rival medtech titan Medtronic. St. Jude will continue with its...

St. Jude Medical beats guidance with Q4 prelims

January 13, 2014 9:03 am | by Mass Device | News | Comments

St. Jude Medical said it's likely to top the high end of its 4th-quarter outlook for both sales and earnings, predicting 4% revenue growth and a bottom-line gain of as much as 154% for the 3 months ended Dec. 28, 2013, compared with the same...

Medtronic's miss muddles the renal denervation landscape

January 13, 2014 7:29 am | by Mass Device | News | Comments

Medtech titan Medtronic (NYSE:MDT) rocked the renal denervation world when it reported earlier this month that it's bellwether Symplicity clinical trial failed to meet efficacy expectations when compared to a sham control arm. Physicians and...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading